Shandong Yingsheng Biotechnology Co., Ltd. established in 2009, is a pioneer in technology development, quality control and technical services in the field of clinical mass spectrometry in China, and also a high-tech enterprise integrating R&D, production, sales and third-party medical testing services. Yingsheng built a leading domestic gene detection platform and mass spectrometry detection platform around metabonomics and genomics, covering the fields of birth defect screening, disease prevention and human health services, and won more than 20 national patents and 6 software copyrights. Participating in the construction of 1 industry standard and 12 enterprise standards, passing the ISO13485 quality management system and GB/T29490-2013 intellectual property management system certification, it is recognized as a core biological technology company in Shandong Province’s "Thirteenth Five-Year Plan".